Service Corporation International (SCI) Q2 2026 Earnings Call Transcript
SCI's second-quarter earnings and revenues beat estimates as cemetery growth and preneed sales rose, while cash flow guidance increased.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Leading oncology journal accepts for publication new CEL-SCI Multikine Phase 3 data.
COLUMBUS, OH / ACCESS Newswire / July 30, 2026 / SCI Engineered Materials, Inc. ("SCI" or "Company") (OTCQB:SCIA), today reported financial results for the three months and six months ended July 30, 2
The headline numbers for Service Corp. (SCI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street esti
Service Corp. (SCI) came out with quarterly earnings of $0.9 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.88 per share a year ago.
On July 24, 2026, Service Corp International (SCI) shares rose 3.8% to $82.33, showing positive momentum in the market. The stock has traded within a 52-week ra
SCI is poised for modest second-quarter revenue growth, supported by preneed cemetery sales and pricing, while soft funeral volumes may have pressured margins.
HOUSTON, July 16, 2026 /PRNewswire/ -- Service Corporation International (NYSE: SCI) announced it expects to issue a press release with financial results for the second quarter 2026 on Wednesday, July
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to launch FDA Registration-Enabling Phase 3 Confirmatory Study to bring Multikine to Market for newly diagnosed head and neck cancer.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #BIO2026--CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care.

CEL-SCI Announces Closing of Offering

04:01pm, Tuesday, 16'th Jun 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of offering.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI advances Multikine immunotherapy for Head and Neck Cancer through dual U.S. registration study and Saudi market entry strategy.
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation announces pricing of offering.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE